This article has multiple issues. Please help improve it or discuss these issues on the talk page. (Learn how and when to remove these template messages) This article is an orphan, as no other articles link to it. Please introduce links to this page from related articles; try the Find link tool for suggestions. (June 2024) This biography of a living person needs additional citations for verification. Please help by adding reliable sources. Contentious material about living persons that is unsourced or poorly sourced must be removed immediately from the article and its talk page, especially if potentially libelous.Find sources: "Carl Faingold" – news · newspapers · books · scholar · JSTOR (June 2024) (Learn how and when to remove this message) A major contributor to this article appears to have a close connection with its subject. It may require cleanup to comply with Wikipedia's content policies, particularly neutral point of view. Please discuss further on the talk page. (June 2024) (Learn how and when to remove this message) This article may require copy editing for grammar, style, cohesion, tone, or spelling. You can assist by editing it. (June 2024) (Learn how and when to remove this message) (Learn how and when to remove this message)

Carl L. Faingold is an American neuroscientist who is a professor in the Department of Pharmacology of Southern Illinois University School of Medicine in Springfield, Illinois; he is a founding faculty member of both the department and the School of Medicine. He has had an extensive career as a medical and graduate student educator as well as a researcher in brain mechanisms. He is a specialist in the actions of drugs on brain activity at the level of the single neuron as it relates to networks of neurons in awake behaving animals.[citation needed]

Education

Faingold received a B.S. in pharmacy from the University of Illinois at Chicago in 1965, and a Ph.D. in pharmacology from Northwestern University in 1970. This was followed by a postdoctoral fellowship at the University of Missouri Institute of Psychiatry.

Research interests

A major research direction in Faingold's lab is in the area of sudden unexpected death in epilepsy (SUDEP), which is a devastating and relatively rare problem that can occur in patients with epilepsy.[1] Since first publishing about a mouse model of SUDEP in 2006 in DBA mice,[2] his lab has explored the role of brain chemicals, serotonin and adenosine, in potential preventative treatments for SUDEP in these mice,[2] including a possible role of agents that enhance the action of serotonin in SUDEP prevention.These agents include selective serotonin reuptake inhibitors (SSRIs) which prevent SUDEP in mice with some evidence of potential usefulness in human epileptic patients as well.[3]

His lab has published several recent papers on the subject of SUDEP prevention in two mouse models of SUDEP in DBA/1 and DBA/2 mice.[4][5]

Publications

He has participated in the writing of the "AMSPC Knowledge Objectives in Pharmacology" as co-editor with Richard Eisenberg, . of the2012 update and expansion of these pharmacology teaching objectives.[6]He also served as co-editor ofBrody's Human Pharmacologywith Lynn Wecker, George Dunaway, Lynn Crespo and Stephanie Watts.[citation needed]

In 2014, he published a book with co-editor, Hal Blumenfeld, Professor of Neurology, Neuroscience and Neurosurgery at Yale University School of Medicine.Neuronal Networks in Brain Function, CNS Disorders, and Therapeutics[7]

Selected works

References

  1. ^ L. Nashef, E. L. So, P. Ryvlin, and T. Tomson. Unifying the definitions of sudden unexpected death in epilepsy. Epilepsia 53 (2):227-233, 2012.
  2. ^ a b S. Tupal and C. L. Faingold. Evidence supporting a role of serotonin in modulation of sudden death induced by seizures in DBA/2 mice. Epilepsia 47 (1):21-26, 2006.
  3. ^ L. M. Bateman, C. S. Li, T. C. Lin, and M. Seyal. Serotonin reuptake inhibitors are associated with reduced severity of ictal hypoxemia in medically refractory partial epilepsy. Epilepsia 51 (10):2211-2214, 2010.
  4. ^ C. L. Faingold and M. Randall. Effects of age, sex, and sertraline administration on seizure-induced respiratory arrest in the DBA/1 mouse model of sudden unexpected death in epilepsy (SUDEP). Epilepsy Behav. 28 (1):78-82, 2013.
  5. ^ C. L. Faingold, S. P. Kommajosyula, X. Long, K. Plath, and M. Randall. Serotonin and sudden death: Differential effects of serotonergic drugs on seizure-induced respiratory arrest in DBA/1 mice. Epilepsy Behav. 37C:198-203, 2014. Faingold CL, Feng HJ. A unified hypothesis of SUDEP: Seizure-induced respiratory depression induced by adenosine may lead to SUDEP but can be prevented by autoresuscitation and other restorative respiratory response mechanisms mediated by the action of serotonin on the periaqueductal gray. Epilepsia. 2023 Epub 2023 Feb 15. PMID 36715572
  6. ^ "Pharmacology Resources | AMSPC". Archived from the original on 2014-11-17. Retrieved 2014-08-15.
  7. ^ Faingold, Carl, and Hal Blumenfeld. Neuronal Networks in Brain Function, CNS Disorders, and Therapeutics. London: Academic Press, 2014. ISBN 9780124158641